In several tumor types, such as liver, breast, ovarian, gastric, colorectal, lung, and pancreatic cancer, elevated expression of PD-L1 has been reported, and it is generally correlated with an unfavorable prognosis [131,132]. This evidence concerns the gene CD274 and pancreatic neoplasm.